BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20695750)

  • 21. [Detection of Exophiala dermatitidis (Kano) De Hoog 1977 in septicemia of a child with acute lymphatic leukemia and in patients with cystic fibrosis].
    Blaschke-Hellmessen R; Lauterbach I; Paul KD; Tintelnot K; Weissbach G
    Mycoses; 1994; 37 Suppl 1():89-96. PubMed ID: 7854373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What can be learned from genotyping of fungi?
    Vanhee LM; Nelis HJ; Coenye T
    Med Mycol; 2010 Nov; 48 Suppl 1():S60-9. PubMed ID: 21067332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scedosporium apiospermum complex in cystic fibrosis; should we treat?
    Noni M; Katelari A; Kapi A; Stathi A; Dimopoulos G; Doudounakis SE
    Mycoses; 2017 Sep; 60(9):594-599. PubMed ID: 28504471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency.
    Kondori N; Gilljam M; Lindblad A; Jönsson B; Moore ER; Wennerås C
    J Clin Microbiol; 2011 Mar; 49(3):1004-9. PubMed ID: 21209163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study.
    de Jong CCM; Slabbers L; Engel TGP; Yntema JB; van Westreenen M; Croughs PD; Roeleveld N; Brimicombe R; Verweij PE; Meis JF; Merkus PJ
    Med Mycol; 2020 Oct; 58(7):859-866. PubMed ID: 32030418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France.
    Paugam A; Baixench MT; Demazes-Dufeu N; Burgel PR; Sauter E; Kanaan R; Dusser D; Dupouy-Camet J; Hubert D
    Med Mycol; 2010 Nov; 48 Suppl 1():S32-6. PubMed ID: 21067327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
    Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
    Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and diversity of filamentous fungi in the airways of cystic fibrosis patients - A Dutch, multicentre study.
    Engel TGP; Slabbers L; de Jong C; Melchers WJG; Hagen F; Verweij PE; Merkus P; Meis JF;
    J Cyst Fibros; 2019 Mar; 18(2):221-226. PubMed ID: 30514613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of Aspergillus species and other moulds in respiratory samples from Argentinean patients with cystic fibrosis.
    Devoto TB; Alava KSH; Pola SJ; Pereda R; Rubeglio E; Finquelievich JL; Cuestas ML
    Med Mycol; 2020 Oct; 58(7):867-873. PubMed ID: 31915834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of fungi in respiratory samples from Turkish cystic fibrosis patients.
    Güngör O; Tamay Z; Güler N; Erturan Z
    Mycoses; 2013 Mar; 56(2):123-9. PubMed ID: 22747891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungal respiratory disease.
    Yao Z; Liao W
    Curr Opin Pulm Med; 2006 May; 12(3):222-7. PubMed ID: 16582678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aspergillus spp. isolations from respiratory tract samples in Trakya University Hospital].
    Gürcan S; Demir M; Altiay G; Tikveşli M; Kiliç H; Otkun M
    Tuberk Toraks; 2007; 55(2):160-6. PubMed ID: 17602344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients.
    Billaud EM; Guillemain R; Berge M; Amrein C; Lefeuvre S; Louët AL; Boussaud V; Chevalier P
    Med Mycol; 2010 Nov; 48 Suppl 1():S52-9. PubMed ID: 21067331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Thomson JM; Wesley A; Byrnes CA; Nixon GM
    Pediatr Pulmonol; 2006 Feb; 41(2):164-70. PubMed ID: 16317722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Relevance of Fungi in Cystic Fibrosis.
    Schwarz C
    Semin Respir Crit Care Med; 2023 Apr; 44(2):252-259. PubMed ID: 36746184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exophiala dermatitidis infection in non-cystic fibrosis bronchiectasis.
    Mukaino T; Koga T; Oshita Y; Narita Y; Obata S; Aizawa H
    Respir Med; 2006 Nov; 100(11):2069-71. PubMed ID: 16626952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity.
    Chotirmall SH; Branagan P; Gunaratnam C; McElvaney NG
    Respir Care; 2008 Aug; 53(8):1035-41. PubMed ID: 18655741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fungal infections and treatment in cystic fibrosis.
    Middleton PG; Chen SC; Meyer W
    Curr Opin Pulm Med; 2013 Nov; 19(6):670-5. PubMed ID: 24060984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.